Literature DB >> 15197462

[Diagnosis and treatment of eyelid eczema. An interdisciplinary challenge].

A Wollenberg1, K Kerschenlohr, T Pavicic, E M Messmer.   

Abstract

Eyelid eczemas are clinically and therapeutically clearly delineated, but remain a pathogenetically heterogeneous entity. The anatomic and functional conditions in the periorbital region make treatment difficult. Thus, in addition to frequent resistance to therapy and a tendency to recur, they pose a considerable diagnostic and therapeutic challenge to dermatologists and ophthalmologists. Even a comparatively small area of eyelid eczema can cause substantial suffering because of the burdensome symptoms and high aesthetic significance of this body region. This interdisciplinary overview deals in particular with current pathogenetic and therapeutic aspects of eyelid eczemas.

Entities:  

Mesh:

Year:  2004        PMID: 15197462     DOI: 10.1007/s00105-004-0759-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  46 in total

1.  Eyelid dermatitis caused by delayed-type hypersensitivity to natural rubber latex.

Authors:  N Katoh; M Murakami; H Yasuno
Journal:  Contact Dermatitis       Date:  1999-06       Impact factor: 6.600

2.  Clinical and immunologic reactivity to aeroallergens in "intrinsic" atopic dermatitis patients.

Authors:  Karin Kerschenlohr; Sandra Decard; Ulf Darsow; Markus Ollert; Andreas Wollenberg
Journal:  J Allergy Clin Immunol       Date:  2003-01       Impact factor: 10.793

3.  [Eyelid eczema. A therapeutic challenge].

Authors:  K Kerschenlohr; U C Schaller; E M Messmer; A Wollenberg
Journal:  Ophthalmologe       Date:  2003-03       Impact factor: 1.059

4.  Characterization of the glucocorticoid receptor in human skin.

Authors:  K M Leiferman; A Schroeter; M K Kirschner; T C Spelsberg
Journal:  J Invest Dermatol       Date:  1983-10       Impact factor: 8.551

Review 5.  Recent developments in latex allergy.

Authors:  Kristiina Turjanmaa; Harri Alenius; Timo Reunala; Timo Palosuo
Journal:  Curr Opin Allergy Clin Immunol       Date:  2002-10

6.  Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.

Authors:  K Sall; O D Stevenson; T K Mundorf; B L Reis
Journal:  Ophthalmology       Date:  2000-04       Impact factor: 12.079

7.  Topical tacrolimus treatment of atopic eyelid disease.

Authors:  Sarah M Rikkers; Gary N Holland; Gail E Drayton; Franz K Michel; Mark F Torres; Stefani Takahashi
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

8.  Impairment of ocular surface epithelium barrier function in patients with atopic dermatitis.

Authors:  K Yokoi; N Yokoi; S Kinoshita
Journal:  Br J Ophthalmol       Date:  1998-07       Impact factor: 4.638

9.  Eyelid dermatitis: experience in 203 cases.

Authors:  Jere D Guin
Journal:  J Am Acad Dermatol       Date:  2002-11       Impact factor: 11.527

10.  Atopic keratoconjunctivitis.

Authors:  C S Foster; M Calonge
Journal:  Ophthalmology       Date:  1990-08       Impact factor: 12.079

View more
  1 in total

Review 1.  [Skin and eyes].

Authors:  E Kohl; J Hillenkamp; M Landthaler; R-M Szeimies
Journal:  Hautarzt       Date:  2009-01       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.